Guardant Health Secures FDA Approval For Expanded Liquid Biopsy Test - Guardant Health (NASDAQ:GH)

Guardant Health secured FDA approval for Guardant360 Liquid CDx, expanding blood-based cancer profiling capabilities.

Raccontata dabenzinga.com